We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$229M
Cap. Flow
-$115M
Cap. Flow %
-7.69%
Top 10 Hldgs %
22.33%
Holding
2,451
New
741
Increased
498
Reduced
386
Closed
708

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$48.3M
2
COL
Rockwell Collins
COL
+$34.6M
3
DELL icon
Dell
DELL
+$33.7M
4
CA
CA, Inc.
CA
+$33.7M
5
NXPI icon
NXP Semiconductors
NXPI
+$23.7M

Sector Composition

Rank Sector Weight
1 Technology 11.52%
2 Communication Services 10.15%
3 Healthcare 7.28%
4 Consumer Discretionary 5.72%
5 Financials 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAIL
1201
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$24K ﹤0.01%
+1,001
New +$25.7K
FLOW
1202
DELISTED
SPX FLOW, Inc.
FLOW
$24K ﹤0.01%
+800
New +$30.2K
SDRL
1203
DELISTED
Seadrill Limited Common Stock
SDRL
$24K ﹤0.01%
2,500
MXWL
1204
DELISTED
Maxwell Technologies Inc
MXWL
$23K ﹤0.01%
+11,267
New +$30.5K
AMC icon
1205
AMC Entertainment Holdings
AMC
$2.31B
$22K ﹤0.01%
176
-14
-7% -$2.29K
EPC icon
1206
CALL
Edgewell Personal Care
EPC
$1.31B
$22K ﹤0.01%
+600
New +$26.2K
SIG icon
1207
Signet Jewelers
SIG
$3.76B
$22K ﹤0.01%
683
+428
+168% +$21.5K
GHDX
1208
DELISTED
Genomic Health, Inc.
GHDX
$22K ﹤0.01%
343
+23
+7% +$1.61K
YELL
1209
DELISTED
Yellow Corporation Common Stock
YELL
$22K ﹤0.01%
+7,000
New +$44.6K
AA icon
1210
PUT
Alcoa
AA
$13.2B
$21K ﹤0.01%
800
-2,400
-75% -$80.7K
ALDX icon
1211
Aldeyra Therapeutics
ALDX
$93.5M
$21K ﹤0.01%
2,572
-1,500
-37% -$15.4K
BURL icon
1212
Burlington
BURL
$23.2B
$21K ﹤0.01%
+129
New +$20.8K
CEVA icon
1213
CEVA Inc
CEVA
$1.08B
$21K ﹤0.01%
959
-437
-31% -$10.9K
IONS icon
1214
Ionis Pharmaceuticals
IONS
$9.4B
$21K ﹤0.01%
395
-15,779
-98% -$805K
IVZ icon
1215
Invesco
IVZ
$13.9B
$21K ﹤0.01%
+1,270
New +$25.4K
NBIX icon
1216
PUT
Neurocrine Biosciences
NBIX
$16.6B
$21K ﹤0.01%
+300
New +$28.7K
ROAD icon
1217
Construction Partners
ROAD
$6.77B
$21K ﹤0.01%
+2,375
New +$23.1K
TGNA
1218
DELISTED
TEGNA Inc
TGNA
$21K ﹤0.01%
1,895
+1,100
+138% +$13.3K
TLRY icon
1219
PUT
Tilray
TLRY
$622M
$21K ﹤0.01%
+30
New +$32.9K
VTV icon
1220
Vanguard Morningstar Value ETF
VTV
$192B
$21K ﹤0.01%
+212
New +$22.3K
TBCH
1221
CALL
Turtle Beach Corp
TBCH
$277M
$21K ﹤0.01%
+1,500
New +$25.8K
FTCH
1222
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$21K ﹤0.01%
+1,200
New +$26K
ALBO
1223
DELISTED
Albireo Pharma Inc
ALBO
$21K ﹤0.01%
858
-1,530
-64% -$40.4K
MSON
1224
DELISTED
Misonix Inc
MSON
$21K ﹤0.01%
+1,299
New +$21.7K
AOS icon
1225
A.O. Smith
AOS
$8.7B
$20K ﹤0.01%
465
-1,874
-80% -$86.2K

Similar funds

Prelude Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Prelude Capital Management held 2,451 positions worth $1.49B, down 13% from $1.72B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Prelude Capital Management withdrew a net $115M in Q4 2018, closing 708 positions and reducing 386 holdings. Its most notable exit was Aetna Inc, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 15% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Red Hat Inc worth $33.2M.

  • Prelude Capital Management's largest Q4 2018 buy was Red Hat Inc: 189,248 shares worth $33.2M.
  • Prelude Capital Management added most to Athenahealth, Inc. in Q4 2018, an estimated $16M increase.
  • Prelude Capital Management's biggest Q4 2018 reduction was Dell, cutting an estimated $33.7M.
  • Prelude Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $48.3M.
  • Prelude Capital Management's ten largest holdings make up 22% of its $1.49B portfolio in Q4 2018.
  • Prelude Capital Management opened 741 new positions and closed 708 in Q4 2018.
  • Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.